PuSH - Publikationsserver des Helmholtz Zentrums München

Pietzner, M.* ; Wheeler, E.* ; Carrasco-Zanini, J.* ; Raffler, J. ; Kerrison, N.D.* ; Oerton, E.* ; Auyeung, V.P.W.* ; Luan, J.* ; Finan, C.* ; Casas, J.P.* ; Ostroff, R.* ; Williams, S.A.* ; Kastenmüller, G. ; Ralser, M.* ; Gamazon, E.R.* ; Wareham, N.J.* ; Hingorani, A.D.* ; Langenberg, C.*

Genetic architecture of host proteins involved in SARS-CoV-2 infection.

Nat. Commun. 11:6397 (2020)
Verlagsversion DOI
Open Access Gold
Creative Commons Lizenzvertrag
Understanding the genetic architecture of host proteins interacting with SARS-CoV-2 or mediating the maladaptive host response to COVID-19 can help to identify new or repurpose existing drugs targeting those proteins. We present a genetic discovery study of 179 such host proteins among 10,708 individuals using an aptamer-based technique. We identify 220 host DNA sequence variants acting in cis (MAF 0.01-49.9%) and explaining 0.3-70.9% of the variance of 97 of these proteins, including 45 with no previously known protein quantitative trait loci (pQTL) and 38 encoding current drug targets. Systematic characterization of pQTLs across the phenome identified protein-drug-disease links and evidence that putative viral interaction partners such as MARK3 affect immune response. Our results accelerate the evaluation and prioritization of new drug development programmes and repurposing of trials to prevent, treat or reduce adverse outcomes. Rapid sharing and detailed interrogation of results is facilitated through an interactive webserver (https://omicscience.org/apps/covidpgwas/).
Weitere Metriken?
Zusatzinfos bearbeiten [➜Einloggen]
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Schlagwörter Association; Disease; Metaanalysis; Reveals; Traits; Target; Risk
ISSN (print) / ISBN 2041-1723
e-ISSN 2041-1723
Zeitschrift Nature Communications
Quellenangaben Band: 11, Heft: 1, Seiten: , Artikelnummer: 6397 Supplement: ,
Verlag Nature Publishing Group
Verlagsort London
Begutachtungsstatus Peer reviewed
Förderungen national "Covid-19 Cardiovascular Disease Flagship Projects"
Cambridge Trust
4-year Wellcome Trust PhD Studentship
University of Cambridge
National Institute on Aging (NIA)
National Institute for Health Research University College London Hospitals Biomedical Research Centre
UCL British Heart Foundation Research Accelerator Award
German Federal Ministry of Education and Research (BMBF)
National Human Genome Research Institute of the National Institutes of Health
Wellcome Trust
UK Medical Research Council
Francis Crick Institute from Cancer Research UK
Medical Research Council